October 2017
Oral Oncolytic Agents: New Caregiver Challenges
January 24, 2018
Article
Partner Perspectives
The use of oral oncolytic agents is on the rise, and these medications now account for a large percentage of all prescribed cancer treatments. Although oral agents offer a convenient alternative to traditional intravenous (IV) chemotherapy, they present new and unique challenges to caregivers.
What to Do When Social Media Lines Are Blurred
October 21, 2017
Article
Feature Story
Use of social media can easily violate patient confidentiality.
Be a Mentor for New Oncology Nurses
October 18, 2017
Article
Fast Facts for the Frontline
Seasoned nurses know the ins and outs of the job, therefore they can be the best resource for those who are just beginning their career.
Improving Adherence to Oral Therapies
October 18, 2017
Article
Cover Story
A process-based approach pulls together the components of care, ensuring a smoother journey for patients.
The Importance of Interdisciplinary Relationships and Oral Adherence
October 12, 2017
Article
Feature Story
Strong interdisciplinary relationships between healthcare providers, specifically pharmacy and nursing, can play a crucial role in patient success with oral chemotherapy regimens.
Angiogenesis Inhibitor Tested in Mesothelioma Trial
October 11, 2017
Article
Clinical Trials in Progress
Although it is estimated that malignant mesothelioma represents less than 1% of all cancers, it is a fatal asbestos-associated malignancy, and patients with MPM tend to be difficult to treat.
How Often Do Vesicant Extravasations Occur?
October 06, 2017
Article
Nurse's Notes
Incidence evaluated at 11 National Cancer Institute–designated cancer centers reveals more about occurrence in day-to-day clinical practice.
Staying on Course: Nurses Have the Power Over Oral Adherence
October 04, 2017
Article
From the Chairman
Discoveries are made every day in the treatment of cancer. Fortunately, many are now in the form of oral drugs, which offer convenience to patients, who can take them from the comfort of their home instead of having to travel to a cancer center. But that easy accessibility comes with a cost: nonadherence.